Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-20Clinical Trial Update: A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults [Phase 3]
Phase 3 trial update for mRNA-1345 vaccine targeting respiratory syncytial virus (RSV) in high-risk adults has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-19Clinical Trial Results: A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. [Phase 2]
Phase 2 trial results for EDP-938 in non-hospitalized adults with RSV at high risk for complications have been completed with results posted…
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of three dose concentrations of an RSV vaccine in infants and toddlers; study terminated …
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Results: Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection [Phase 2]
Phase 2 trial results for Obeldesivir in children with RSV infection have been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose [Phase 3]
A Phase 3 trial evaluating revaccination in subsequent pregnancies with a bivalent RSV vaccine and the duration of protection from a single …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products [Phase 4]
Phase 4 clinical trial update evaluating the immunology and safety of maternal RSV vaccination ABRYSVO and infant nirsevimab BEYFORTUS, alon…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV [Phase 1]
An update on a Phase 1 trial evaluating JCXH-108, an mRNA-based vaccine for respiratory syncytial virus (RSV) infection, developed by Immorn…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older [Phase 1]
A Phase 1 study of a vaccine candidate against respiratory syncytial virus, metapneumovirus, and parainfluenza virus type 3 in adults aged 6…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevimab [Phase 3]
A Phase 3 study evaluating safety, pharmacokinetics, anti-drug antibodies, and anti-RSV antibodies after two doses of nirsevimab has complet…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above [Phase 1]
This clinical trial update summarizes a Phase 1 study assessing the safety and immunogenicity of the IN006 RSV vaccine in healthy adults age…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India [Phase 4]
Phase 4 trial update of Nirsevimab for RSV immunization in children up to 24 months in India; the study is currently active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay
The completed clinical evaluation studied the VitaSIRO Solo Respiratory Assay for detecting respiratory pathogens, including SARS-CoV-2/COVI…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control [Phase 3]
A Phase 3 follow-up safety study assessing participants who received RSVPreF3 maternal vaccination or controls, with results posted for preg…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Safety of RSV Preventive Monoclonal Antibody [Phase 4]
Phase 4 trial update assessing the safety of an RSV preventive monoclonal antibody. The study is currently recruiting and monitors adverse e…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating an RSV and human metapneumovirus vaccine candidate sponsored by Sanofi Pasteur.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study of Modified mRNA Vaccines in Healthy Adults [Phase 1]
A Phase 1 study of modified mRNA vaccines in healthy adults sponsored by ModernaTX, Inc. has completed, evaluating vaccines targeting COVID-…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older [Phase 2]
Phase 2 study of a Sanofi Pasteur respiratory syncytial virus vaccine candidate in adults aged 60 years and older has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants [Phase 3]
A clinical trial update indicating completion of a Phase 3 study evaluating the efficacy and safety of TNM001 in high-risk infants with Resp…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory
A completed clinical trial evaluated the impact of the 2025 Infant and Maternal RSV Prevention Program on RSV-related hospitalizations in th…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants [Phase 2, Phase 3]
A Phase 2/3 trial evaluating TNM001 for the prevention of lower respiratory tract infections caused by respiratory syncytial virus in infant…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children [Phase 1]
A Phase 1 trial completed and results posted evaluating infectivity, safety, and immunogenicity of two RSV vaccine candidates, RSV 6120/∆NS1…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older [Phase 2]
A Phase 2 study evaluating the immunogenicity and safety of a recombinant respiratory syncytial virus vaccine in adults aged 60 and older; t…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea [Phase 3]
Pfizer completed a Phase 3 trial in Korea evaluating the safety, tolerability, and immunogenicity of the RSVpreF vaccine in older adults. Re…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants
This clinical trial update reports the real-world effectiveness of nirsevimab against respiratory syncytial virus–related infections and all…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers [Phase 3]
Phase 3 study evaluating the immunogenicity and safety of three RSV vaccine dose concentrations in infants and toddlers; the trial has been …